Oncologists' recognition of depression in their patients with cancer

scientific article published on April 1, 1998

Oncologists' recognition of depression in their patients with cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1200/JCO.1998.16.4.1594
P953full work available at URLhttp://intl.jco.org/cgi/content/abstract/16/4/1594
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.1998.16.4.1594
P698PubMed publication ID9552071

P2093author name stringS. Edgerton
D. E. Theobald
M. V. McDonald
B. Rosenfeld
W. Dugan
S. D. Passik
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectpatientQ181600
P304page(s)1594-1600
P577publication date1998-04-01
P1433published inJournal of Clinical OncologyQ400292
P1476titleOncologists' recognition of depression in their patients with cancer
P478volume16

Reverse relations

cites work (P2860)
Q73974765"I'm sorry to tell you ..." physicians' reports of breaking bad news
Q33729034"What concerns me is..." Expression of emotion by advanced cancer patients during outpatient visits
Q33981845A Comparison of the Renal Cell Carcinoma-Symptom Index (RCC-SI) and the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).
Q35801735A brief symptom index for advanced lung cancer
Q89957403A qualitative approach in determining the patient-centered information and supportive care needs of cancer patients in Singapore
Q49256878A simple filter model to guide the allocation of healthcare resources for improving the treatment of depression among cancer patients
Q73634547A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population
Q44839381Adolescent survivors of childhood cancer: are they vulnerable for psychological distress?
Q37738177Advances in quality of life research among head and neck cancer patients
Q35862164Agreement for depression diagnosis between DSM-IV-TR criteria, three validated scales, oncologist assessment, and psychiatric clinical interview in elderly patients with advanced ovarian cancer
Q36626916An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder
Q52065319An attempt to employ the Zung Self-Rating Depression Scale as a "lab test" to trigger follow-up in ambulatory oncology clinics: criterion validity and detection
Q48506093An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients
Q55266062Analysis of psychosocial stress factors in patients with renal cancer.
Q47946477Antidepressant prescribing in community cancer care
Q36718619Antidepressant use in ambulatory cancer patients
Q81156895Anxiety and the blues after breast cancer: how common are they?
Q33759223Anxiety disorders in advanced cancer patients: correlates and predictors of end-of-life outcomes
Q53500690Are healthcare providers adequate raters of patients' quality of life--perhaps more than we think?
Q35910445Assessment of depression severity with the PHQ-9 in cancer patients and in the general population
Q51044661Assessment of psychological distress in prospective bone marrow transplant patients
Q33841133Assessment of the older cancer patient
Q91950059Association between depression and healthcare expenditures among elderly cancer patients
Q46077129Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial
Q46915278Associations between Plasma Cytokines and Depressive Mood in Patients with Breast Cancer
Q50532563Associations of Physical and Psychologic Symptom Burden in Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
Q40709856Biomedical and psychosocial determinants of psychiatric morbidity among postoperative ambulatory breast cancer patients
Q37119191Breast cancer follow-up in the adjuvant setting
Q30661280Cancer distress screening data: translating knowledge into clinical action for a quality response
Q45209908Cancer patients' reluctance to discuss psychological distress with their physicians was not associated with underrecognition of depression by physicians: a preliminary study.
Q36609609Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience
Q33583900Characteristics of attempted suicide by patients with schizophrenia compared with those with mood disorders: a case-controlled study in northern Japan
Q33558690Childhood adversity and herpesvirus latency in breast cancer survivors
Q40311680Chronic therapy with selective serotonin reuptake inhibitors and survival in newly diagnosed cancer patients
Q46587232Clinic-based depression screening in lung cancer patients using the PHQ-2 and PHQ-9 depression questionnaires: a pilot study
Q51113807Clinical experience of the modified nurse-assisted screening and psychiatric referral program
Q48217561Clinical indicators of depression among ambulatory cancer patients undergoing chemotherapy
Q36440120Clinical practice guidelines for the management of psychosocial distress at the end of life
Q47918708Comparison of four brief depression screening instruments in ovarian cancer patients: Diagnostic accuracy using traditional versus alternative cutpoints
Q88560402Computer-based monitoring and evaluation of epilepsy-related health variables and their impact on treatment decision
Q37352665Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology
Q46273620Correlates of depressive symptoms among women seeking cancer genetic counseling and risk assessment at a high-risk cancer clinic
Q40823331Correlates of oncologist-issued referrals for psycho-oncology services: what we learned from the electronic voluntary screening and referral system for depression (eVSRS-D).
Q45953908Correlation of radiation treatment interruptions with psychiatric disease and performance status in head and neck cancer patients
Q47347512Criterion validation of the Edinburgh postnatal depression scale as a screening tool for depression in patients with advanced metastatic cancer
Q39471599Depressed patients with incurable cancer: which depressive symptoms do they experience?
Q36622795Depression Treatment in Individuals with Cancer: A Comparative Analysis with Cardio-Metabolic Conditions
Q34642766Depression and barriers to mental health care in older cancer patients
Q35237260Depression and end-of-life care for patients with cancer
Q45325033Depression assessment by oncologists and palliative care physicians
Q35634135Depression in cancer patients: a critical review
Q44321759Depression is associated with some patient-perceived cosmetic changes, but not with radiotherapy-induced late toxicity, in long-term breast cancer survivors
Q37029143Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer.
Q80439335Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome
Q34605151Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer
Q30238703Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review.
Q79335050Depressive symptoms during and after radiotherapy for head and neck cancer
Q44415376Depressive symptoms in advanced cancer. Part 2. Depression over time; the role of the palliative care professional
Q81403035Descriptive analysis of clinical factors affecting terminally ill cancer patients
Q53046021Development and Validation of 11 Symptom Indexes to Evaluate Response to Chemotherapy for Advanced Cancer
Q57653189Development and validation of eleven symptom indexes to evaluate response to chemotherapy for advanced cancer: Measurement compliance with regulatory demands
Q51948926Development of a brief screening interview for adjustment disorders and major depression in patients with cancer
Q48315237Development of guidelines for distress management in Korean cancer patients
Q49055973Diagnosis and treatment of depression in patients with advanced illness
Q44037250Distress and quality of life in primary high-grade brain tumor patients.
Q35762243Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress
Q34135620Do claimants over-report behavioral health dysfunction when filing for work disability benefits?
Q36034212Do rates of mental disorders and existential distress among advanced stage cancer patients increase as death approaches?
Q57031058Doctor's recommendations for psychosocial care: Frequency and predictors of recommendations and referrals
Q40682504Drug interactions between antineoplastic and antidepressant agents: analysis of patients seen at an oncology clinic at a general hospital
Q35354379Early referral to supportive care specialists for symptom burden in lung cancer patients: a comparison of non-Hispanic whites, Hispanics, and non-Hispanic blacks
Q51902857Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial
Q33807805Effect of sex and gender on psychosocial aspects of prostate and breast cancer
Q34440359Effect of telecare management on pain and depression in patients with cancer: a randomized trial
Q36453878Effectiveness of health-related quality-of-life measurement in clinical practice: a prospective, randomized controlled trial in patients with chronic liver disease and their physicians.
Q38936349Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer.
Q47574538Empathy and the failure to treat pain
Q58283102Euthanasia and physician-assisted suicide
Q36231171Euthanasia: An Indian perspective
Q34730661Evaluation of psychosocial distress in patients treated in a community-based oncology group practice in Germany
Q81841950Factors that influence physicians' detection of distress in patients with cancer: can a communication skills training program improve physicians' detection?
Q42772667Fatigue in cancer
Q44438545Fluoxetine Versus Placebo in Advanced Cancer Outpatients: A Double-Blinded Trial of the Hoosier Oncology Group
Q42963369Follow-up after breast cancer
Q48727139Frequency of depression among oncology outpatients and association with other symptoms
Q89890239Gaps in the Management of Depression Symptoms Following Cancer Diagnosis: A Population-Based Analysis of Prospective Patient-Reported Outcomes
Q48900441Hematology/oncology fellows' training in palliative care: results of a national survey
Q36622443How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling?
Q49035618Identifying tumor patients' depression
Q92400330Impact of Onset of Psychiatric Disorders and Psychiatric Treatment on Mortality Among Patients with Cancer
Q39376991Impact of psychological screening on routine outpatient care of hematopoietic cell transplantation survivors
Q39342839Impact of surgical wound dehiscence on health-related quality of life and mental health.
Q36470419Implementing evidence-based psychological treatments for cancer patients
Q47879981Implications of a needs assessment intervention for people with progressive cancer: impact on clinical assessment, response and service utilisation
Q37390123Improving primary care for older adults with cancer and depression
Q35569155Improving the psychological care of cancer patients and their relatives. The role of specialist nurses
Q35792639Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study.
Q58288989Information exchange in oncology outpatient clinics: source, valence and uncertainty
Q35624527Insulin and cancer
Q38672371Integrating Psychosocial Care Into Routine Cancer Care.
Q46511856Integrating mental health screening and abnormal cancer screening follow-up: an intervention to reach low-income women
Q24202217Interventions to improve continuity of care in the follow-up of patients with cancer
Q24240264Interventions to improve continuity of care in the follow-up of patients with cancer
Q53500694Is 'bedside medicine' returning to oncology?
Q35073461Is race/ethnicity related to the presence or severity of pain in colorectal and lung cancer?
Q92446638Liaison psychiatry in a central nervous system tumor service
Q33816624Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment
Q36514293Longitudinal comparison of three depression measures in adult cancer patients.
Q38027186Measurement of Health‐Related Quality of Life in the Care of Patients with ESRD: Isn’t This the Metric That Matters?
Q48941889Measurement of psychological distress in patients with intracranial tumours: the NCCN distress thermometer
Q46258198Mental adjustment to cancer: the role of anxious and depressive symptoms under treatment
Q37823816Novel Approaches to Perioperative Assessment and Intervention May Improve Long-Term Outcomes After Colorectal Cancer Resection in Older Adults
Q48608072Nurses' recognition of the mental state of cancer patients and their own stress management ― a study of Japanese cancer‐care nurses
Q48069915On the need for comprehensive assessment of impact of comorbidity in elderly patients with head and neck cancer
Q35176995Oncologists' perception of depressive symptoms in patients with advanced cancer: accuracy and relational correlates
Q36010668Oncologists’ assessments of lung cancer patient and family disagreements regarding treatment decision making
Q37203645Oncology outpatient and provider responses to a computerized symptom assessment system
Q52167333Oncology staff recognition of depressive symptoms on videotaped interviews of depressed cancer patients: implications for designing a training program
Q34363581Opioid misuse behaviors in adolescents and young adults in a hematology/oncology setting.
Q90217965Opportunities to Improve Detection and Treatment of Depression Among Patients With Breast Cancer Treated in an Integrated Delivery System
Q30331774Palliative care provision and its impact on psychological morbidity in cancer patients.
Q97531650Parallel Journeys of Patients with Cancer and Depression: Challenges and Opportunities for Technology-Enabled Collaborative Care
Q85183757Patient Benefits From Psychosocial Care: Screening for Distress and Models of Care
Q33884399Patient and staff perceptions of cancer patients' psychological concerns and needs
Q37249363Patient-physician communication about health-related quality-of-life problems: are non-Hodgkin lymphoma survivors willing to talk?
Q77105497Patients’ Perceptions of Receiving Bad News About Cancer
Q50639207Patients’ negative emotional cues and concerns in hospital consultations: A video-based observational study
Q34696378Patterns and predictors of antidepressant use in ambulatory cancer patients with common solid tumors
Q50085733Performance of four diagnostic approaches to depression in adults with cancer.
Q47344748Performance status 1 predicts psychological response in female, but not male, ambulatory cancer patients
Q33247628Physician-assisted suicide: a review of the literature concerning practical and clinical implications for UK doctors
Q73589038Predicting anxiety and depression among cancer patients: a clinical model
Q74715777Predictive factors for suicidal ideation in patients with unresectable lung carcinoma
Q46874972Prevalence of Abnormal Echocardiographic Findings in Cancer Patients: A Retrospective Evaluation of Echocardiography for Identifying Cardiac Abnormalities in Cancer Patients
Q50755245Prevalence of depression among cancer patients in Jordan: a national survey
Q43419174Prevalence of depression among relatives of cancer patients in Jordan: a cross-sectional survey
Q34848420Prevalence of depression and anxiety in patients requesting physicians' aid in dying: cross sectional survey
Q34806874Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments
Q46324032Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
Q33768621Prevalence of emotional symptoms in Chilean oncology patients before the start of chemotherapy: potential of the distress thermometer as an ultra-brief screening instrument
Q51976408Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer
Q36791086Primary extraosseous Ewing sarcoma of the lung in children
Q48494151Priority Symptoms in Advanced Breast Cancer: Development and Initial Validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16)
Q43824293Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma
Q34599819Psychiatric disorders and mental health service use in patients with advanced cancer: a report from the coping with cancer study
Q36936909Psychiatric disorders in advanced cancer
Q36622912Psychiatric morbidity and its recognition by doctors in patients with cancer
Q37962252Psycho-Oncology: Structure and Profiles of European Centers Treating Patients With Gynecological Cancer
Q36989817Psychological Status and Associated Factors among Korean Cancer Survivors: a Cross-Sectional Analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys
Q35875041Psychological health in cancer survivors
Q37203840Psychological intervention reduces postembolization pain during hepatic arterial chemoembolization therapy: a complementary approach to drug analgesia
Q40988835Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship
Q79805988Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation
Q60621970Psychosocial problems secondary to cancer
Q48588526Psychosocial supportive care for children receiving stem cell transplantation: practice patterns across centers
Q33274849Quality of life in patients with chordomas/chondrosarcomas during treatment with proton beam therapy.
Q35099020Quality of life information and trust in physicians among families of children with life-limiting conditions
Q33837258Quality of life instruments in oncology
Q39704040Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Non-Small Cell Lung Cancer: A SEER Cohort Study
Q37121640Randomized controlled trial of collaborative care management of depression among low-income patients with cancer
Q36695588Rapid screening for depression--validation of the Brief Case-Find for Depression (BCD) in medical oncology and palliative care patients
Q90382930Rational Suicide in Late Life: A Systematic Review of the Literature
Q36868626Receipt of Psychosocial Care Among Cancer Survivors in the United States
Q24671683Recognition of depression by non-psychiatric physicians--a systematic literature review and meta-analysis
Q38209521Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force
Q47283829Relationship between physicians' perceived stigma toward depression and physician referral to psycho-oncology services on an oncology/hematology ward.
Q36095796Review and critique of the quality of exercise recommendations for cancer patients and survivors
Q44316133Routine screening for psychological distress on an Australian inpatient haematology and oncology ward: impact on use of psychosocial services
Q50988694Routine screening for psychosocial distress following hematopoietic stem cell transplantation
Q39769469Screening for distress and supportive care needs during the initial phase of the care process: a qualitative description of a clinical pilot experiment in a French cancer center
Q34432415Screening for distress, the 6th vital sign: common problems in cancer outpatients over one year in usual care: associations with marital status, sex, and age
Q35820240Screening for emotional distress in cancer patients: a systematic review of assessment instruments
Q50977718Screening for psychologic distress in ambulatory cancer patients
Q34467192Screening for psychological distress in patients with lung cancer: results of a clinical audit evaluating the use of the patient Distress Thermometer
Q51701181Screening for psychological distress in two French cancer centers: feasibility and performance of the adapted distress thermometer
Q92726816Serious illness care Programme UK: assessing the 'face validity', applicability and relevance of the serious illness conversation guide for use within the UK health care setting
Q44119419Standardized geriatric assessment or comprehensive gerontological assessment: where do we stand?
Q37513262Stress generation over the course of breast cancer survivorship
Q35599063Studies of comprehensive geriatric assessment in patients with cancer
Q48873235Suicide in women with gynecologic cancer
Q48188176Symptoms overlooked in hospitalized cancer patients: Impact of concurrent symptoms on overlooked by nurses
Q50920236Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer: a cancer and leukemia group B study
Q30327168The 'right kind' of pain: talking about symptoms in outpatient oncology consultations.
Q35629577The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients
Q34590031The Distress Thermometer and Its Validity: A First Psychometric Study in Indonesian Women with Breast Cancer
Q47952282The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up
Q37346617The Indiana Cancer Pain and Depression (INCPAD) trial Design of a telecare management intervention for cancer-related symptoms and baseline characteristics of study participants
Q33978339The James Supportive Care Screening: integrating science and practice to meet the NCCN guidelines for distress management at a Comprehensive Cancer Center
Q37796537The Oncologist's Role in Delivering Palliative Care
Q37796549The Oncologist's Role in Managing Depression, Anxiety, and Demoralization With Advanced Cancer
Q34107655The association of depression and pain with health-related quality of life, disability, and health care use in cancer patients
Q31029367The association of mood disorders with breast cancer survival: an investigation of linked cancer registration and hospital admission data for South East England
Q39462416The cancer psychosocial care matrix: a community‐derived evaluative tool for designing quality psychosocial cancer care delivery
Q40721909The changeable nature of patients' fears regarding chemotherapy: implications for palliative care
Q33464696The effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in cancer patients treated with radiotherapy: design of a cluster randomised controlled trial
Q36390235The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review
Q58590756The global burden of multiple chronic conditions: A narrative review
Q34009204The importance of quality-of-life endpoints in clinical trials to the practicing oncologist
Q82810555The measure of psychological distress in cancer patients: the use of Distress Thermometer in the Oncological Rehabilitation Center of Florence
Q48627293The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer
Q35805736The quality of medical care at the end-of-life in the USA: existing barriers and examples of process and outcome measures
Q37305210The role of primary care physicians in cancer care
Q48716661The role of trait emotional intelligence in the diagnostic cancer pathway
Q34070144The usefulness and feasibility of a screening instrument to identify psychosocial problems in patients receiving curative radiotherapy: a process evaluation.
Q46204642Tobacco use among long-term survivors of head and neck cancer treated with radiation therapy
Q34095808Towards the Implementation of Quality of Life Monitoring in Daily Clinical Routine: Methodological Issues and Clinical Implication
Q40493557Treatment of depression in cancer and non-cancer patients in German neuropsychiatric practices
Q35600438Treatment-related symptoms among underserved women with breast cancer: the impact of physician-patient communication
Q35584773Tumor Epidermal Growth Factor Receptor Genotype and Depression in Stage IV Non-Small Cell Lung Cancer
Q61444891Twelve Chinese herbal preparations for the treatment of depression or depressive symptoms in cancer patients: a systematic review and meta-analysis of randomized controlled trials
Q39937311Unmet supportive needs of cancer patients in an acute care hospital in Japan--a census study
Q44233595Use of a depression screening tool and a fluoxetine-based algorithm to improve the recognition and treatment of depression in cancer patients. A demonstration project
Q52551121Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation
Q48895468Usefulness of pharmacist‐assisted screening and psychiatric referral program for outpatients with cancer undergoing chemotherapy
Q81528873Usefulness of the nurse-assisted screening and psychiatric referral program
Q36654637Validation and reliability of distress thermometer in Chinese cancer patients
Q47383248Validation of the distress and impact thermometer and the changes of mood during the first 6 months of treatment in gynecological cancer patients: a Kansai Clinical Oncology Group (KCOG)-G1103 prospective study.
Q46965723Validation of the emotion thermometers and hospital anxiety and depression scales in Singapore: Screening cancer patients for distress, anxiety and depression
Q44247043Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patients.
Q47618017What type and dose of antidepressants are cancer and non-cancer inpatients being prescribed: a retrospective case-control study at an Australian tertiary hospital
Q36135211Who Provides Psychosocial Follow-Up Care for Post-Treatment Cancer Survivors? A Survey of Medical Oncologists and Primary Care Physicians
Q45788530Why patient recorded outcomes should be mandatory in and outside clinical trials to guide management of patients with metastatic breast cancer

Search more.